Authors:
Rendi-Wagner, P
Kundi, M
Stemberger, H
Wiedermann, G
Holzmann, H
Hofer, M
Wiesinger, K
Kollaritsch, H
Citation: P. Rendi-wagner et al., Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience, VACCINE, 19(15-16), 2001, pp. 2055-2060
Authors:
Mandl, CW
Kroschewski, H
Allison, SL
Kofler, R
Holzmann, H
Meixner, T
Heinz, FX
Citation: Cw. Mandl et al., Adaptation of tick-borne encephalitis virus to BHK-21 cells results in theformation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo, J VIROLOGY, 75(12), 2001, pp. 5627-5637
Citation: R. Kaiser et H. Holzmann, Laboratory findings in tick-borne encephalitis - Correlation with clinicaloutcome, INFECTION, 28(2), 2000, pp. 78-84
Authors:
Mandl, CW
Allison, SL
Holzmann, H
Meixner, T
Heinz, FX
Citation: Cw. Mandl et al., Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site, J VIROLOGY, 74(20), 2000, pp. 9601-9609
Authors:
Puchhammer-Stockl, E
Mandl, CW
Kletzmayr, J
Holzmann, H
Hofmann, A
Aberle, SW
Heinz, FX
Watschinger, B
Hofmann, H
Citation: E. Puchhammer-stockl et al., Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy, J INFEC DIS, 181(6), 2000, pp. 2063-2066
Authors:
Mandl, CW
Aberle, JH
Aberle, SW
Holzmann, H
Allison, SL
Heinz, FX
Citation: Cw. Mandl et al., In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model, NAT MED, 4(12), 1998, pp. 1438-1440